Federated Hermes Inc. Has $19.93 Million Stake in Revvity, Inc. (NYSE:RVTY)

Federated Hermes Inc. boosted its stake in Revvity, Inc. (NYSE:RVTY - Free Report) by 7.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 190,030 shares of the company's stock after buying an additional 13,203 shares during the quarter. Federated Hermes Inc. owned approximately 0.15% of Revvity worth $19,927,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. Czech National Bank lifted its holdings in shares of Revvity by 0.5% during the first quarter. Czech National Bank now owns 21,713 shares of the company's stock valued at $2,280,000 after acquiring an additional 99 shares during the period. TriaGen Wealth Management LLC lifted its holdings in Revvity by 2.3% during the 2nd quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company's stock valued at $500,000 after purchasing an additional 107 shares during the last quarter. Guinness Asset Management LTD boosted its position in Revvity by 3.3% in the second quarter. Guinness Asset Management LTD now owns 3,587 shares of the company's stock valued at $376,000 after buying an additional 116 shares in the last quarter. Inspire Investing LLC grew its stake in Revvity by 2.9% during the first quarter. Inspire Investing LLC now owns 4,190 shares of the company's stock worth $440,000 after buying an additional 117 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. grew its stake in Revvity by 3.6% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,899 shares of the company's stock worth $409,000 after buying an additional 135 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Revvity news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.60% of the company's stock.

Revvity Trading Up 0.6 %

NYSE RVTY traded up $0.77 on Monday, reaching $122.80. The company had a trading volume of 608,251 shares, compared to its average volume of 837,498. The company has a quick ratio of 1.98, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $128.15. The stock has a market cap of $15.15 billion, a price-to-earnings ratio of 101.20, a PEG ratio of 2.87 and a beta of 1.05. The stock's 50 day moving average is $117.37 and its 200-day moving average is $110.06.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The business had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. During the same quarter last year, the firm earned $1.21 EPS. Revvity's quarterly revenue was down 2.5% compared to the same quarter last year. Equities analysts predict that Revvity, Inc. will post 4.75 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.23%. The ex-dividend date is Friday, October 18th. Revvity's payout ratio is presently 23.14%.

Analyst Ratings Changes

RVTY has been the topic of several recent analyst reports. Leerink Partners initiated coverage on Revvity in a report on Monday, July 8th. They issued an "outperform" rating and a $125.00 target price on the stock. Citigroup increased their target price on Revvity from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, July 30th. Jefferies Financial Group lifted their price target on Revvity from $115.00 to $125.00 and gave the company a "hold" rating in a report on Monday, July 29th. Wells Fargo & Company initiated coverage on shares of Revvity in a report on Tuesday, August 27th. They set an "equal weight" rating and a $130.00 price objective on the stock. Finally, JPMorgan Chase & Co. upped their target price on shares of Revvity from $105.00 to $120.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 30th. Eight investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $126.00.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.